Novo Nordisk A/S ($NVO) Insider Trading & Smart Money Activity

Novo Nordisk A/S · Drug Manufacturers - General · Latest filing Oct 15, 2026

Novo Nordisk A/S ($NVO) has 4 congress trades and 3 13F position changes on file.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
4
13F moves on file
3
Analyst ratings on file
0

NVO insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 1 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 0
Q3 2026 0 0 1 / 2 0 / 0
Q4 2026 0 0 0 / 0 0 / 2

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All NVO insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
13F HCR Wealth Advisors Sold out -5.91K sh —
13F Generate Investment Management Sold out -350K sh Read
Congress Kevin Hern Sale $1,001 - $15,000 -1.9%-12.3% Read
Congress Kevin Hern Sale $1,001 - $15,000 -0.4%-16.4% —
Congress Scott Franklin Purchase $1,001 - $15,000 -0.9%-17.8% —
Congress Alan Armstrong Purchase $15,001 - $50,000 +3.9%+14.2%+11.1% —
13F Tiger Global Management Sold out -1.27M sh —

1W / 1M / 6M = how NVO moved from the trade or filing date.

Members of Congress trading NVO

Institutions moving NVO (13F)

Frequently asked questions

Which members of Congress traded NVO?

4 disclosed trades by Kevin Hern, Scott Franklin and Alan Armstrong. The latest was on Sep 10, 2026.

Which institutions changed their NVO positions?

Recent 13F filers moving the stock include HCR Wealth Advisors, Generate Investment Management and Tiger Global Management.

Other drug manufacturers - general stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text